Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Furtim Therapeutics LLC
Profile last edited on: 9/20/2018      CAGE: 7MZ43      UEI: CQ3MV2N991K4

Business Identifier: Bio-conjugation for therapeutic applications
Year Founded
2016
First Award
2017
Latest Award
2017
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4000 Mason Road Suite 304
Seattle, WA 98105
   (425) 273-1035
   N/A
   www.furtimtx.com
Location: Single
Congr. District: 07
County: King

Public Profile

Furtim Therapeutics LLC specializes in bio-conjugation for therapeutic applications. The firm's PI has expertise in bio-conjugate purification, Conjugate biochemical characterization. Acute Lymphoblastic Leukemia, Animal sera analysis, immunogenicity, pharmacokinetics, pharmacodynamics, animal protocol development.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$225,000
Phase II Dollars
$0
Total Awarded
$225,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2017 1 NSF $225,000
Project Title: Development, Optimization and Analysis of Poly (Carboxy Betaine) Bio-conjugates to L-Asparagianse as PEGylation Alternatives

Key People / Management

  George Sellhorn -- Principal

  Wenchen Li -- Research Scientist

Company News

There are no news available.